Trisomy 8 clonal expansion during disease progression and azacitidine resistance in VEXAS syndrome: a case report.

Saved in:
Bibliographic Details
Title: Trisomy 8 clonal expansion during disease progression and azacitidine resistance in VEXAS syndrome: a case report.
Authors: Sato K; Department of Hematology, Japanese Red Cross Nagano Hospital, Nagano, Japan., Zaimoku Y; Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan.; Innovate Clinical Research Center, Kanazawa University Hospital, Kanazawa, Japan., Kano Y; Department of Clinical Laboratory Science, Division of Health Sciences, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan., Kobayashi M; Department of Clinical Laboratory Science, Division of Health Sciences, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan., Kazama S; Department of Hematology, Japanese Red Cross Nagano Hospital, Nagano, Japan., Morikawa T; Department of Hematology, Japanese Red Cross Nagano Hospital, Nagano, Japan., Kazumoto H; Department of Hematology, Japanese Red Cross Nagano Hospital, Nagano, Japan., Ishii W; Department of Rheumatology, Japanese Red Cross Nagano Hospital, Nagano, Japan., Ueki T; Department of Hematology, Japanese Red Cross Nagano Hospital, Nagano, Japan., Sumi M; Department of Hematology, Japanese Red Cross Nagano Hospital, Nagano, Japan., Kobayashi H; Department of Hematology, Japanese Red Cross Nagano Hospital, Nagano, Japan., Nannya Y; Division of Hematopoietic Disease Control, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Ogawa S; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.; Department of Innovative Medicine, Faculty of Medicine, Kindai University, Osakasayama, Japan., Ichikawa N; Department of Medical Oncology, Japanese Red Cross Nagano Hospital, Nagano, Japan.
Source: Frontiers in immunology [Front Immunol] 2026 Jun 10; Vol. 17, pp. 1841156. Date of Electronic Publication: 2026 Jun 10 (Print Publication: 2026).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2026.1841156